BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24879130)

  • 1. Impact of diabetes mellitus on the outcome of pancreatic cancer.
    Beg MS; Dwivedi AK; Ahmad SA; Ali S; Olowokure O
    PLoS One; 2014; 9(5):e98511. PubMed ID: 24879130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of diabetes mellitus on clinical outcomes in patients undergoing surgical resection for pancreatic cancer: a retrospective, cohort study.
    Hart PA; Law RJ; Frank RD; Bamlet WR; Burch PA; Petersen GM; Rabe KG; Chari ST
    Am J Gastroenterol; 2014 Sep; 109(9):1484-92. PubMed ID: 25070053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma.
    He XY; Li JF; Yao WY; Yuan YZ
    Ann Surg Oncol; 2013 Nov; 20(12):3809-16. PubMed ID: 23943021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer.
    Chiao EY; Nambi PV; Naik AD
    J Cancer Surviv; 2010 Dec; 4(4):381-7. PubMed ID: 20721633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of preoperative diabetes on long-term survival after curative resection of pancreatic adenocarcinoma: a systematic review and meta-analysis.
    Walter U; Kohlert T; Rahbari NN; Weitz J; Welsch T
    Ann Surg Oncol; 2014 Apr; 21(4):1082-9. PubMed ID: 24322532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis.
    Amin S; Mhango G; Lin J; Aronson A; Wisnivesky J; Boffetta P; Lucas AL
    Am J Gastroenterol; 2016 Sep; 111(9):1350-7. PubMed ID: 27430290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy.
    Choi Y; Kim TY; Oh DY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    Cancer Res Treat; 2016 Jan; 48(1):171-9. PubMed ID: 25779362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus is associated with unfavorable pathologic features, increased postoperative mortality, and worse long-term survival in resected pancreatic cancer.
    Hank T; Sandini M; Qadan M; Weniger M; Ciprani D; Li A; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Pancreatology; 2020 Jan; 20(1):125-131. PubMed ID: 31706821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.
    Lee S; Hwang HK; Kang CM; Lee WJ
    Pancreas; 2018 Aug; 47(7):816-822. PubMed ID: 29975349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study.
    Balzano G; Dugnani E; Gandolfi A; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
    PLoS One; 2016; 11(11):e0166008. PubMed ID: 27814399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of diabetes mellitus on clinical outcomes of pancreatic cancer after surgical resection: A systematic review and meta-analysis.
    Lv X; Qiao W; Leng Y; Wu L; Zhou Y
    PLoS One; 2017; 12(2):e0171370. PubMed ID: 28158300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma.
    Chu CK; Mazo AE; Goodman M; Egnatashvili V; Sarmiento JM; Staley CA; Galloway JR; Adsay NV; Jacobs S; Kooby DA
    Ann Surg Oncol; 2010 Feb; 17(2):502-13. PubMed ID: 19885697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of diabetes mellitus on clinical outcomes following chemotherapy for the patients with pancreatic cancer: a meta-analysis.
    Ma J; Wang J; Ge L; Long B; Zhang J
    Acta Diabetol; 2019 Oct; 56(10):1103-1111. PubMed ID: 31069497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
    Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
    Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting.
    Thukkani AK; Agrawal K; Prince L; Smoot KJ; Dufour AB; Cho K; Gagnon DR; Sokolovskaya G; Ly S; Temiyasathit S; Faxon DP; Gaziano JM; Kinlay S
    J Am Coll Cardiol; 2015 Sep; 66(10):1091-101. PubMed ID: 26337986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Postoperative Occurrence or Worsening of Diabetes Mellitus May Increase the Risk of Recurrence in Resected Pancreatic Neuroendocrine Tumors.
    de Mestier L; Védie AL; Faron M; Cros J; Rebours V; Hentic O; Do Cao C; Bardet P; Lévy P; Sauvanet A; Ruszniewski P; Hammel P
    Neuroendocrinology; 2020; 110(11-12):967-976. PubMed ID: 31791037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of diabetes and perineural invasion in pancreatic cancer.
    Sahin IH; Shama MA; Tanaka M; Abbruzzese JL; Curley SA; Hassan M; Li D
    Cancer Med; 2012 Dec; 1(3):357-62. PubMed ID: 23342285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two different types of diabetes mellitus in pancreatic cancer population. Comparative study between new onset and long standing diabetes mellitus on 76 patients with pancreatic cancer.
    Tanţău A; Negrean V; Alexescu T; Para I; Tărmure S; Casoinic F; Sâmpelean D; Mocanu T; Tanţău M
    Rom J Intern Med; 2014; 52(1):18-23. PubMed ID: 25000673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinoma.
    Morales-Oyarvide V; Mino-Kenudson M; Ferrone CR; Sahani DV; Pergolini I; Negreros-Osuna AA; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
    Pancreatology; 2017; 17(6):920-926. PubMed ID: 28890154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-onset diabetes patients need pancreatic cancer screening?
    Lee JH; Kim SA; Park HY; Lee KH; Lee KT; Lee JK; Bae JC; Kim KW
    J Clin Gastroenterol; 2012 Aug; 46(7):e58-61. PubMed ID: 22138846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.